Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2023-02-22 00:00:00 ET · period of report 2023-02-22 · accession 0001140361-23-008049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-22 | 2023-02-22 | ROIV | Ramaswamy Vivek | Dir | S - Sale | $7.95 | -4.00M | 54.41M | -7% | -$31.80M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-02-22 | S | D | 4,000,000 | $7.95 | 54,409,211 | D | — | — | (F1) The reporting person does not expect to sell additional shares of the Issuer for the foreseeable future. (F2) Reflects an award of restricted stock covering Common Shares that is fully vested. |